U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07209020) titled 'HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery' on Sept. 22.
Brief Summary: The goal of this clinical trial is to evaluate the safety of the collagen wound dressing (HealiAid) in breast tumor patients with surgical treatment. The main questions it aims to answer are:
1. To record the incidence of the postoperative complications and adverse events (AEs) after applying the HealiAid wound dressing in patients undergoing surgery for breast tumor.
2. To evaluate the patients' satisfaction and quality of life using the Breast Q questionnaire before surgery and at weeks 2, 12, 26, and 52 after the surgery.
3...